https://www.selleckchem.com/pr....oducts/4-aminobutyri
Colorectal cancer is currently the third leading cause of cancer-related deaths and recently, alternative splicing has risen as its important regulator and potential treatment target. In the present study, we analyzed gene expression of the MBNL family of regulators of alternative splicing in various stages of colorectal cancer development, together with the MBNL-target splicing events in FOXP1 and EPB41L3 genes and tumor-related CD44 variants. Samples of tumor tissue and non-malignant mucosa from 108 patients were collected
Like
Comment
Share
